International Journal of Antimicrobial Agents

Article	Citations
Title Page & Editorial Board	78
Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapy	76
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	73
A retrospective observational cohort study of the clinical epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae in an OXA-48 endemic setting	66
Cystathionine γ-lyase: The Achilles heel of bacterial defense systems	64
A contribution on the fosfomycin mechanism of resistance in multidrug-resistant organisms	55
Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole gen	54
Lopinavir and ritonavir act synergistically with azoles against Candida auris in vitro and in a mouse model of disseminated candidiasis	53
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	51
Daptomycin non-susceptible Staphylococcus argenteus isolated from a patient without prior antibiotic exposure	48
Daily fluid intake as a novel covariate affecting the population pharmacokinetics of polymyxin B in patients with sepsis	48
Antifungal activity and potential mechanism of action of caspofungin in combination with ribavirin against Candida albicans	48
Erratum to “Empiric antibiotic protocols for cancer patients with neutropenia: a single–center study of treatment efficacy and mortality in patients with bacteremia” [International Journal of Antimicr	47
Colistin- and tigecycline-resistant CTX-M-14-producing Salmonella enterica serovar Kentucky ST198 from retail chicken meat, China	46
The New Delhi metallo-β-lactamase-1 biosensor rapidly and accurately detected antibiotic plasma concentrations in cefuroxime-treated patients	45
Large-scale comparative analysis reveals phylogenomic preference of blaNDM-1 and blaKPC-2 transmission among Klebsiella pneumoniae	43
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	41
Title Page & Editorial Board	41
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	36
Heterogeneous Vancomycin Intermediate Staphylococcus aureus infections in tertiary care hospitals in Coastal Karnataka, India	36
Mycobacterium species on the cutaneous microbiome of very preterm neonates admitted to the NICU in a tertiary health care hospital	35
Antimicrobial therapy for carbapenem-resistant gram-negative bacteria	34
Emergence of intrinsically resistant Gram-negative bacteria with an environmental primary habitat	34
Vaccines against SARS-COV-2	33
In vitro activity of β-lactam-β-lactam enhancer combination, cefepime/zidebactam (WCK 5222, FEP/ZID) against multi-clonal, colistin-resistant Klebsiella pneumoniae	33

Hospitalization decision model for COVID-19 patients with comorbidities	32
Effectiveness of rifampicin combination therapy for orthopaedic implant-related infections: A systematic review and meta-analysis	32
Severe Salmonella enteritidis infection complicated with colonic perforations and abdominal cocoon	32
Immunomodulator AS101 restores colistin susceptibility of clinical colistin-resistant Escherichia coli and Klebsiella pneumoniae in vitro and in vivo	31
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	31
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	30
Outcomes of Daptomycin Plus Ceftaroline Versus Alternative Therapy for Persistent Methicillin-resistant Staphylococcus aureus (MRSA) Bacteraemia	29
Antibiotic spectrum index as an antimicrobial stewardship tool in paediatric intensive care settings	28
Efficacy of clofazimine-containing regimens for treatment of Mycobacterium avium complex–pulmonary disease in patients unsuitable for standard treatment regimen	28
Global prevalence of fosfomycin resistance genes fosA and fosB in multidrug-resistant bacteria	28
Impact of a newly established expert clinical pharmacological advice programme based on therapeutic drug monitoring results in tailoring antimicrobial therapy hospital-wide in a tertiary university ho	28
Dysbiosis of the gut microbiota is associated with in-hospital mortality in patients with antibiotic-associated diarrhoea: A metagenomic analysis	27
Characterization of the genome of a Klebsiella pneumoniae clinical strain carrying a novel KPC-205 variant associated with resistance to ceftazidime/avibactam and cefiderocol	27
Development of a new antibiotic-induced dysbiosis model of the canine colonic microbiota	27
Microdialysis sampling to monitor target-site vancomycin concentrations in septic infants: a feasible way to close the knowledge gap	26
Machine learning accelerates the discovery of epitope-based dual-bioactive peptides against skin infections	26
Antibiotic resistance in Enterobacter hormaechei	26
Proguanil and chlorhexidine augment the antibacterial activities of clarithromycin and rifampicin against Acinetobacter baumannii	25
Resistance profiling and molecular characterization of methicillin-resistant Staphylococcus pseudintermedius isolated from dogs and cats	24
EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci	24
Extended infusion improves meropenem and piperacillin/tazobactam effectiveness in septic burn patients with normal renal by applying pharmacokinetics-pharmacodynamics approach	24
Psychological effects of paramedics by experience of managing COVID-19 patients	24
How I treat CMV infection in high-risk pediatric patients?	24
Demography and antibiotic susceptibility of emerging Chryseobacterium gleum among hospitalised patients in Malaysia	24
Safety and efficacy of a phage cocktail on murine wound infections caused by carbapenem-resistant Klebsiella pneumoniae	23
Intravenous Fosfomycin as Adjunctive Therapy for Gram-Negative Bacteria Bloodstream Infections: A Propensity Score Adjusted Retrospective Cohort Study	23
INDIVIDUALIZED AMOXICILLIN-CLAVULANATE DOSING RECOMMENDATIONS FOR CRITICALLY ILL CHILDREN WITH AUGMENTED CLEARANCE AFTER CARDIAC SURGERY	23
Cross-talk between signal transduction systems and metabolic networks in antibiotic resistance and tolerance	23
Global evolutionary dynamics of virulence genes in ST11-KL47 carbapenem-resistant Klebsiella pneumoniae	23
Treatment of infections caused by multidrug-resistant Gram-negative bacilli: A practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases	22
Clinical and laboratory insights into the threat of hypervirulent Klebsiella pneumoniae	22
Pretomanid resistance: An update on emergence, mechanisms and relevance for clinical practice	22
MRSA surveillance programmes worldwide: moving towards a harmonised international approach	21
Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically ill patients	21
Aerosolized plus intravenous polymyxin B in comparison to intravenous polymyxin B alone for the management of HAP caused by carbapenem-resistant gram-negative bacteria: A prospective multicenter cohor	20
Effectiveness of mRNA BNT162b2 and inactivated CoronaVac vaccines against severe COVID-19 outcomes among non-hospitalised children aged 1-3 years with SARS-CoV-2 Omicron infection	20
Comparing outcomes among outpatients treated for pyelonephritis with oral cephalosporins versus first-line agents	20
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	20
Detection of mcr-1-harbouring Escherichia coli by quantum dot labelling of synthetic small peptides mimicking lipopolysaccharide receptors	20
In reply to the Letter to the Editor regarding Intrathecal or intraventricular antimicrobial therapy for post-neurosurgical Gram-negative bacillary meningitis or ventriculitis: A systematic review and	20
Metagenomic next-generation sequencing on treatment strategies and prognosis of patients with lower respiratory tract infections: A systematic review and meta-analysis	20
A Systematic Review of the Pharmacokinetics and Pharmacodynamics of Novel Beta-Lactams and Beta-Lactam with Beta-Lactamase Inhibitor Combinations for the Treatment of Pneumonia Caused by Carbapenem-Re	20
Efficacy of combination therapy with standard-dose carbapenem for treating nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii in intensive care units: A multicentre retrospect	19
Systematic review and meta-analysis to explore optimal therapeutic range of vancomycin trough level for infected paediatric patients with Gram-positive pathogens to reduce mortality and nephrotoxicity	19
Silent dissemination of fosfomycin resistance genes in critical-priority Klebsiella pneumoniae	19
Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-ce	19
Characterization of the extended substrate spectrum of the class A β-lactamase CESS-1 from Stenotrophomonas sp. and structure-based investigation into its substrate preference	19
Alterins, a new family of marine antibacterial cyclolipopeptides	19
In vitro susceptibilities of isolates of potentially naturally inducible chromosomal AmpC-producing metallo-β-lactamase-negative carbapenem-resistant Enterobacterales species to ceftazidime-avibactam:	19
Temocillin versus carbapenems for urinary tract infection due to ESBL-producing Enterobacteriaceae: a multicenter matched case-control study	18

Impact of pre‐existent drug resistance on virological efficacy of single‐tablet regimens in people living with HIV	18
Title Page & Editorial Board	18
Population pharmacokinetics of levornidazole in healthy subjects and patients, and sequential dosing regimen proposal using pharmacokinetic/pharmacodynamic analysis	18
Zanamivir and baloxavir combination to cure persistent influenza and coronavirus infections after hematopoietic stem cell transplant	18
PROGRAM-AT-A-GLANCE	18
Zidovudine in synergistic combination with fosfomycin: an in vitro and in vivo evaluation against multidrug-resistant Enterobacterales	18
Variability in oral antibiotic step-down therapy in the management of Gram-negative bloodstream infections	18
Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistance	18
Study on antibiotic resistance of Staphylococcus aureus isolated in Hue University hospital in 2018 and 2019	17
High diversity of blaNDM-1-encoding plasmids in Klebsiella pneumoniae isolated from neonates in a Vietnamese hospital	17
Plasma, intracellular and lymph node antiretroviral concentrations and HIV DNA change during primary HIV infection: Results from the INACTION P25 study	17
Eczematous skin colonization pattern with potential bacterial pathogens in paediatric population at a tertiary care setting, in Sri Lanka	17
Genomic characterization of vancomycin-resistant Enterococcus faecium transmission in hospital by whole genome sequencing	17
The surveillance of colistin resistance and mobilized colistin resistance genes in multidrug-resistant Enterobacteriaceae isolated in Japan	17
Title Page & Editorial Board	17
Antimicrobial susceptibility and co-resistance among Pseudomonas aeruginosa isolates from hospital-acquired respiratory-tract infections: SMART 2017–2019 Malaysia	17
Novel active Trp- and Arg-rich antimicrobial peptides with high solubility and low red blood cell toxicity designed using machine learning tools	17
Intrapulmonary pharmacokinetics of high doses of tigecycline in patients with ventilator-associated pneumonia	16
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing	16
Mechanisms and fitness of ceftazidime/avibactam-resistant Klebsiella pneumoniae clinical strains in Taiwan	16
Clinical outcomes of rifampicin combination therapy in implant-associated infections due to staphylococci and streptococci: A systematic review and meta-analysis	16
Title Page & Editorial Board	16
Colistin resistance genes mcr-1 to mcr-5, including a case of triple occurrence (mcr-1, -3 and -5), in Escherichia coli isolates from faeces of healthy pigs, cattle and poultry in Belgium, 2012–2016	16
High concentrations of nirmatrelvir/ritonavir in critically ill patients receiving continuous renal replacement therapy	16
Comparative efficacy of dalbavancin alone and with rifampicin against in vitro biofilms in a pharmacodynamic model with methicillin-resistant Staphylococcus aureus	16
Staphylococcus aureus bacteraemia treatment outcomes in patients receiving ticagrelor vs a propensity-matched cohort receiving clopidogrel	16
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based	16
The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM)	16
Title Page & Editorial Board	16
Longitudinal fluctuations of common antimicrobial resistance genes in the gut microbiomes of healthy Dutch individuals	15
Beware of resistance to 2nd-generation integrase inhibitors: A systematic meta-analysis of HIV-1 integrase inhibitors resistance and drug resistance mutations	15
Global distribution of blaCMY-42, a gene mediating reduced susceptibility to aztreonam-avibactam and ceftazidime-avibactam, in Escherichia coli	15
Immunogenicity of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in people living with HIV on combination antiretroviral therapy	15
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	15
Molecular investigation of an epidemic dissemination of vancomycin-resistant Enterococcus faecium sequence type 80 in Guangdong province, China	15
Isavuconazole dosing in Asian patients with invasive mould infections: is there a role for therapeutic drug monitoring?	15
Verapamil enhances the activity of Caspofungin against Cryptococcus neoformans， coinciding with inhibited Ca2+/CN pathway and damage to cell wall integrity	15
Toxoplasma gondii infection or acute retinal necrosis in early stage: A case report	15
Shifting trends in bloodstream infection-causing microorganisms and their clinical impact in patients with haematologic malignancies in South Korea: A propensity score-matched study	15
Corrigendum to “Clinical and Economic Evaluation of Blood Culture Whole Process Optimisation in Critically Ill Adult Patients With Positive Blood Cultures” [International Journal of Antimicrobial Agen	15
Assessment of cefepime toxicodynamics: comprehensive examination of pharmacokinetic/pharmacodynamic targets for cefepime-induced neurotoxicity and evaluation of current dosing guidelines	14
A review of recently discovered mechanisms of cephalosporin resistance in Pseudomonas aeruginosa	14
Pharmacodynamics of ceftriaxone for the treatment of methicillin‐susceptible Staphylococcus aureus: is it a viable treatment option?	14
Respiratory fluoroquinolone monotherapy for community-acquired pneumonia: a revised trial sequential analysis	14
Audit of empirical antibiotic therapy for sepsis and the impact of early multidisciplinary consultation on patient outcomes.	14
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	14
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	14
Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent infusion or continuous infusion	14
NDM-5-producing carbapenem-resistant Klebsiella pneumoniae of sequence type 789 emerged as a threat for neonates: a multicentre, genome-based study	14
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	14
Functional characterization and clinical implication of a novel epidemic carbapenem-resistant Acinetobacter baumannii genetic marker	14
Corrigendum to “Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and	14
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	14
Evaluation of synergistic activity of fosfomycin in combination with novel ß-lactams/ß-lactamase inhibitor combinations (βL-βLICs) against KPC-producing Klebsiella pneumoniae clinical isolates	13
Emergence of ceftazidime-avibactam resistance in blaKPC-33-harbouring ST11 Klebsiella pneumoniae in a paediatric patient	13
In-silico identification of novel inhibitors for glutamate racemase (MurI) to decipher the subtle of antimicrobial resistance in Neisseria gonorrhoeae: A virtual screening and molecular dynamics appro	13
Risk of Clostridioides difficile infection following different antibiotics: insights from multi-source medical data	13
Safety of high loading doses of teicoplanin: POSY-TEICO, a prospective, multicentre, observational study	13
In-vitro activity of oral third-generation cephalosporins plus clavulanate against ESBL-producing Enterobacterales isolates from the MERINO trial	13
Analysis of time-to-positivity data in tuberculosis treatment studies: Identifying a new limit of quantification	13
Ferric chloride induces ferroptosis in Pseudomonas aeruginosa and heals wound infection in a mouse model	13
Nafcillin Augmentation of Daptomycin and Cathelicidin LL-37 Killing of Methicillin-resistant Staphylococcus epidermidis: Foundations of Successful Therapy of Endocarditis	13
Characteristic of Stenotrophomonas maltophilia antimicrobial profile in Malaysian isolates 2015–2020	13
What we learned from COVID-19 vaccination	13
Tigecycline heteroresistance and resistance mechanism in clinical isolates of Acinetobacter baumannii	13
Pleural penetration of amoxicillin and metronidazole during pleural infection: An ambispective cohort study	13
Clinical efficacy of ceftazidime/avibactam combination therapy for severe hospital-acquired pulmonary infections caused by carbapenem-resistant and difficult-to-treat Pseudomonas aeruginosa	13
Acute kidney injury associated with colistin sulfate vs. polymyxin B sulfate therapy: A real-world, retrospective cohort study	13
Evaluation of tetracycline and fluoroquinolone therapy against Japanese spotted fever: Analysis based on individual data from case reports and case series	13
Title Page & Editorial Board	13
Tracking emergence and outbreak of Klebsiella pneumoniae co-producing NDM-1 and KPC-2 after sulfamethoxazole-trimethoprim treatment: Insights from genetic analysis	13
A case of atypical hemolytic uremic syndrome caused by Escherichia fergusonii mimicking Escherichia coli in an immunocompetent adult	13
High-throughput mutagenesis and screening approach for the identification of drug-resistant mutations in the rifampicin resistance-determining region of mycobacteria	13
High-level delafloxacin resistance through the combination of two different mechanisms in Staphylococcus aureus	13
Pharmacokinetic and preclinical safety studies of endolysin-based therapeutic for intravenous administration	13
Pharmacodynamic and immunomodulatory effects of polymyxin B in combination with fosfomycin against KPC-2-producing Klebsiella pneumoniae	13
How to combine novel techniques with stewardship: A real-world experience	12
Optimising culture results of orthopaedic infections using blood culture bottles	12
Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals	12
Disruption of biofilms and killing of Burkholderia cenocepacia from cystic fibrosis lung using an antioxidant-antibiotic combination therapy	12

High prevalence of clonally related ST182 NDM-1-producing Enterobacter cloacae complex clinical isolates in Greece	12
Comparative efficacy and safety of systemic antifungal agents for candidemia: a systematic review with network meta-analysis and multicriteria acceptability analyses	12
Human tissue distribution of caspofungin	12
Antimicrobial surveillance: A 20-year history of the SMART approach to addressing global antimicrobial resistance into the future	12
Pro) Piperacillin-tazobactam for ESBL-producing Enterobacterales	12
Genomic characterization of phenotypically carbapenem-resistant Escherichia coli isolates carrying unknown resistance genes in Malaysia	12
Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials	12
In vivo selection of KPC-94 and KPC-95 in Klebsiella pneumoniae isolates from patients treated with ceftazidime/avibactam	12
Renal function and its impact on the concentration of ceftazidime-avibactam: A cross-sectional study	12
Rising threat of metallo-β-lactamase-producing Klebsiella oxytoca complex in Taiwan, 2013-2022	12
High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial	12
Multicentre Clinical Evaluation of a Molecular Diagnostic Assay to Identify Neisseria gonorrhoeae Infection and Detect Antimicrobial Resistance	12
Con) Piperacillin-tazobactam for ESBL-producing Enterobacterales	12
BPI23-Fcγ alleviates lethal multi-drug-resistant Acinetobacter baumannii infection by enhancing bactericidal activity and orchestrating neutrophil function	12
REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSI	12
Optimal dosing regimen of biapenem based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation in patients with febrile neutropenia and haematological malignancies	12
Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain	12
Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover cli	12
FL058, a novel β-lactamase inhibitor, increases the anti-Mycobacterium abscessus activity of imipenem	12
Susceptibility of Southeast Asian Plasmodium falciparum isolates to P218	11
Letter to the Editor regarding: Ceftriaxone exposure in patients undergoing extracorporeal membrane oxygenation	11
In Vivo emergence of ceftazidime/avibactam, cefiderocol and aztreonam/avibactam cross-resistance in a patient with KPC-producing infection after cefiderocol-based treatment	11
Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: New data from CREDIBLE-CR with an updated meta-analysis	11
Intravenous to oral antibiotics versus intravenous antibiotics: a step-up or a step-down for extended spectrum β-lactamase (ESBL)-producing urinary tract infections without concomitant bacteraemia?	11
Intravenous fosfomycin in combination regimens as a treatment option for difficult-to-treat infections due to multi-drug-resistant Gram-negative organisms: A real-life experience	11
Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns	11
Impact of mass and systematic antibiotic administration on antibiotic resistance in low- and middle-income countries. A systematic review	11
Optimised cefiderocol exposures in a successfully treated critically ill patient with polymicrobial Stenotrophomonas maltophilia bacteraemia and pneumonia receiving continuous venovenous haemodiafiltr	11
Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections	11
Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study	11
Long-term effects of ciprofloxacin treatment on the gastrointestinal and oropharyngeal microbiome are more pronounced after longer antibiotic courses	11
Susceptibility of OXA-48-producing Enterobacterales to imipenem/relebactam, meropenem/vaborbactam and ceftazidime/avibactam	11
Persistence and dynamic structures of diverse cephalosporinase genes in nontyphoidal Salmonella in cross-sectional surveillance in Taiwan	11
New options for bloodstream infections caused by colistin‐ or ceftazidime/avibactam‐resistant Klebsiella pneumoniae	11
A novel indolylbenzoquinone compound HL-J6 suppresses biofilm formation and α-toxin secretion in methicillin-resistant Staphylococcus aureus	11
Access to phage therapy at Hospices Civils de Lyon in 2022: Implementation of the PHAGEinLYON Clinic programme	10
Plasma effects on bacterial time-kill dynamics: Insights from a PK/PD modelling analysis	10
Title Page & Editorial Board	10
Clinical and laboratory factors in predicting mortality among SARS-CoV-2 RNA positive patients from a tertiary care center in South Tamilnadu – A retrospective observational study	10
Role of tcaA, a potential target as a ceftobiprole resistance breaker in MRSA β-lactam resistance	10
A 22-year Brazilian colistin resistance surveillance on Escherichia coli and Salmonella spp. originating from food-producing animals	10
Reviewer Thank you List 2021	10
Pattern and appropriateness of antibiotic prescriptions for upper respiratory tract infections in primary care paediatric patients	10
Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy vs. monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the O	10
Strategies for quorum sensing inhibition as a tool for controlling Pseudomonas aeruginosa infections	10
Enhancing the identification of voriconazole-associated hepatotoxicity by targeted metabolomics	10
In vitro activity of WCK 5222 (cefepime/zidebactam) against bioterror pathogen Burkholderia pseudomallei	10
Clinical features and outcomes of vancomycin-resistant enterococcal meningitis in neonatal intensive care unit patients: presentation of three cases	10
A translational rat model to assess glomerular function changes with vancomycin	10
IGRA-based INH regimen for prevention of active tuberculosis after kidney transplantation: A single-centre retrospective study	10
Cellular and genetic changes during and after fluconazole exposure in Cryptococcus neoformans	10
Extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in humans and from food-producing animals in Italy: a ‘One Health’ study	10
The antimicrobial activity of innate host-directed therapies: A systematic review	10
Sequential treatment effects on phage–antibiotic synergistic application against multi-drug-resistant Acinetobacter baumannii	10
The dlt operon contributes to the resistance to chlorhexidine in Streptococcus mutans	10
Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial	10
The Trifecta of Diagnostic Stewardship, Antimicrobial Stewardship, and Value Assessment of New Diagnostic Tests	10
The epidemiology and clinical spectrum of melioidosis in a tertiary hospital in a north-eastern state of Malaysia: A three-year review	10
The emergence of transposon-driven multidrug resistance in invasive nontypeable Haemophilus influenzae over the last decade	10
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	10
Title Page & Editorial Board	10
Two natural compounds as potential inhibitors against the Helicobacter pylori and Acinetobacter baumannii IspD enzymes	10
Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial	9
Clinical effectiveness of molnupiravir in patients with COVID-19 undergoing haemodialysis	9
Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae	9
Delivery of endolysin across outer membrane of Gram-negative bacteria using translocation domain of botulinum neurotoxin	9
Head-to-head comparison of multi-dose oritavancin and dalbavancin for complicated infections: A propensity score-matched analysis	9
Nomogram for the prediction of tigecycline-induced hypofibrinogenaemia in a Chinese population	9
Should the trough concentration of vancomycin be abandoned in therapeutic drug monitoring? A multicentre, retrospective study of critically ill patients without any form of dialysis	9
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity	9
The evolution of carbapenem-resistant Pseudomonas aeruginosa in the COVID-19 era: A global perspective and regional insights	9
Genetic alterations in methicillin-susceptible Staphylococcus aureus associated with high vancomycin minimum inhibitory concentration	9
Investigating an outbreak of extensively drug-resistant Acinetobacter baumannii in a tertiary healthcare centre in lebanon using next-generation sequencing	9
Models for cytotoxicity screening of antileishmanial drugs: what has been done so far?	9
Indocyanine green clearance test as a predictor of linezolid overexposure in septic patients	9
Candida parapsilosis isolates carrying mutations outside FKS1 hotspot regions confer high echinocandin tolerance and facilitate the development of echinocandin resistance	9
Evaluation of deoxythymidine-based cationic amphiphiles as antimicrobial, antibiofilm, and anti-inflammatory agents	9
Blockade of pan-viral propagation by inhibition of host cell PNPT1	9
Resistance to aztreonam-avibactam among clinical isolates of Escherichia coli is primarily mediated by altered penicillin-binding protein 3 and impermeability	9
In vitro activities of ceftazidime–avibactam, ceftolozane–tazobactam, meropenem–vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Dat	9
Trial Sequential Analysis of Intrathecal/Intraventricular Antimicrobial Therapy for Post-Neurosurgical Gram-Negative Bacillary Meningitis or Ventriculitis	9
Molecular typification of Escherichia coli from community-acquired urinary tract infections in Mexico	9
In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020	9
Anti-Porphyromonas gingivalis nanotherapy for maintaining bacterial homeostasis in periodontitis	9
Intestinal colonisation with hypervirulent or third-generation cephalosporin-resistant Klebsiella pneumoniae strains upon hospital admission in a general ward in Taiwan	9
In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in the Asia-Pacific region: SMART 2017-2020	9
Investigation of PhoP response regulator inhibition to overcome resistance in Gram-negative clinical bacteria	9
Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeabilit	9
Efficacy of adding azithromycin to antibiotic prophylaxis in caesarean delivery: a meta-analysis and systematic review	8
Clonal outbreak of NDM-1-producing Enterobacter hormaechei belonging to high-risk international clone ST78 with the coexistence of tmexCD2-toprJ2 and mcr-9 in China	8
Effect of pre-hospitalization use of oral antiviral agents on reducing critical illness and mortality for patients with COVID-19 pneumonia	8
Voriconazole therapeutic drug monitoring and hepatotoxicity in critically ill patients: A nationwide multi-centre retrospective study	8
Small-molecule antiviral treatments for COVID-19: A systematic review and network meta-analysis	8
Effect of achieving bone sterilisation on bone architecture and bone marrow, in an experimental rabbit model of osteomyelitis caused by carbapenemase-producing Enterobacterales	8
In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification	8